Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast CancerMaria A. Papadaki(University of Crete), Sofia Agelaki(University of Crete)CancersFebruary 6, 202010.3390/cancers12020376Cited by 88SaveCiteExport RISWatch citationsRelated PapersEpithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients|Breast Cancer Research|2011|373Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer|PLoS ONE|2015|58Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes|Molecular Oncology|2017|17